Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 4/20 | 0.61 |
| ▸ | PPARA | Q07869 | 4/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 6/20 | 0.60 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.60 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.60 |
| ▸ | MAOA | P21397 | 1/20 | 0.59 |
| ▸ | MAOB | P27338 | 1/20 | 0.59 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.59 |
| ▸ | TUBB1 | Q9H4B7 | 2/20 | 0.55 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.51 |
| ▸ | TUBB | P07437 | 1/20 | 0.51 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.51 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.51 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.51 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.51 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.51 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.51 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.51 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.51 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6230114 | 1.00 | PPARG (0.61) | PPARGPPARACYP19A1ALOX5PTGS2 | |
| SCHEMBL16199999 | 0.95 | ABCB1 (0.57) | PPARGPPARACYP19A1ALOX5PTGS2 | |
| SCHEMBL6228549 | 0.92 | ABCB1 (0.60) | PPARGPPARACYP19A1ALOX5PTGS2 | |
| SCHEMBL6228547 | 0.92 | ABCB1 (0.60) | PPARGPPARACYP19A1ALOX5PTGS2 | |
| SCHEMBL16199962 | 0.89 | PPARG (0.80) | PPARGPPARAMAOBPPARD | |
| SCHEMBL16200005 | 0.89 | MAOB (0.76) | PPARGPPARACYP19A1ALOX5PTGS2 | |
| SCHEMBL16199920 | 0.88 | CYP19A1 (0.72) | PPARGPPARACYP19A1ALOX5PTGS2 | |
| SCHEMBL16200144 | 0.88 | MAOA (0.62) | PPARGPPARACYP19A1ALOX5PTGS2 | |
| SCHEMBL16200113 | 0.87 | ALOX5 (0.52) | PPARGPPARACYP19A1ALOX5PTGS2 | |
| SCHEMBL16199906 | 0.87 | CYP19A1 (0.58) | PPARGPPARACYP19A1ALOX5PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119925454-A | Application of cajan leaf in rats with chronic myelosuppression caused by MTX | 浙江中医药大学 | 2025-05-06 | — | — | CN | disclosed |
| US-11795127-B2 | Processes for the preparation of ortho-allylated hydroxy aryl compounds | MCMASTER UNIVERSITY (CA) | 2023-10-24 | — | — | US | disclosed |
| US-11795127-B2 | Processes for the preparation of ortho-allylated hydroxy aryl compounds | MCMASTER UNIVERSITY (CA) | 2023-10-24 | — | — | US | disclosed |
| US-20230113567-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2023-04-13 | — | — | US | disclosed |
| US-20210380513-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2021-12-09 | — | — | US | disclosed |
| WO-2021237371-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | MCMASTER UNIVERSITY (CA) | 2021-12-02 | — | — | WO | disclosed |
| US-10760062-B2 | Biosynthesis of phenylpropanoids and phenylpropanoid derivatives | EVOLVA SA (CH) | 2020-09-01 | — | — | US | disclosed |
| EP-2796442-B1 | CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE | INST MED BIOTECHNOLOGY CAMS (CN) | 2019-03-27 | — | — | EP | disclosed |
| US-20180142216-A1 | Biosynthesis of Phenylpropanoid and Dihydrophenylpropanoid Derivatives | DANSTAR FERMENT AG (CH) | 2018-05-24 | — | — | US | disclosed |
| US-20180142216-A1 | Biosynthesis of Phenylpropanoid and Dihydrophenylpropanoid Derivatives | DANSTAR FERMENT AG (CH) | 2018-05-24 | — | — | US | disclosed |
| US-20140371232-A1 | CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE | INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2014-12-18 | — | — | US | disclosed |
| EP-2796442-A1 | CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE | Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences (CN) | 2014-10-29 | — | — | EP | disclosed |
| EP-1311257-B1 | COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS | INSMED INC (US) | 2005-04-27 | — | — | EP | disclosed |
| EP-1311257-A2 | COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS | Insmed Incorporated (US) | 2003-05-21 | — | — | EP | disclosed |
| US-6552085-B2 | For lowering blood glucose in a mammal | INSMED INCORPORATED | 2003-04-22 | — | — | US | disclosed |
| US-6410596-B1 | FOR LOWERING BLOOD GLUCOSE IN A MAMMAL | INSMED INCORPORATED | 2002-06-25 | — | — | US | disclosed |
| US-20020058707-A1 | COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS | INSMED INCORPORATED | 2002-05-16 | — | — | US | disclosed |
| US-20020058701-A1 | Compositions containing hypoglycemically active stilbenoids | SHAMAN PHARMACEUTICALS | 2002-05-16 | — | — | US | disclosed |
| WO-2002013811-A2 | COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS | INSMED INCORPORATED (US) | 2002-02-21 | — | — | WO | disclosed |
| WO-2002014252-A2 | COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS | INSMED INCORPORATED (US) | 2002-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230113567-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | ADH1A, ADH1C, AHR | PPARG 543/4885PPARA 231/4885CYP19A1 77/4885 |
| US-20020058707-A1 | COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS | SLC5A2, SLC5A1, SLC2A1 | PPARG 1187/4885PPARA 479/4885CYP19A1 207/4885 |
| US-20210380513-A1 | PROCESSES FOR THE PREPARATION OF ORTHO-ALLYLATED HYDROXY ARYL COMPOUNDS | ADH1A, ADH1C, AHR | PPARG 543/4885PPARA 231/4885CYP19A1 77/4885 |
| US-20140371232-A1 | CAJANINE STRUCTURE ANALOGOUS COMPOUND, PREPARATION METHOD AND USE | ACHE, GAP43, LNPK | PPARG 3419/4885PPARA 2766/4885CYP19A1 1479/4885 |
| US-11795127-B2 | Processes for the preparation of ortho-allylated hydroxy aryl compounds | ADH1A, ADH1C, AHR | PPARG 543/4885PPARA 231/4885CYP19A1 77/4885 |
| US-20020058701-A1 | Compositions containing hypoglycemically active stilbenoids | SLC5A2, SLC5A1, SLC2A1 | PPARG 1187/4885PPARA 479/4885CYP19A1 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.